Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Australia

Australia

In Australia, the Digestives & Intestinal Remedies market market generates a revenue of AU €195.20m in 2024.
It is projected to experience an annual growth rate of 3.25% (CAGR 2024-2029).
When compared globally, in China leads the market with a revenue of AU €4,045.00m in 2024.
In terms of per capita figures, each person in Australia generates AU €7.31 in revenue in 2024.
Australia's growing interest in natural remedies has led to an increase in demand for herbal digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Digestives & Intestinal Remedies market in Australia has experienced significant growth in recent years, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in Australia are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are becoming more conscious of the ingredients used in these products and are willing to pay a premium for those that are perceived as healthier and more sustainable. This shift in customer preferences has led to a rise in demand for natural and herbal remedies in the Digestives & Intestinal Remedies market.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Australia is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They are believed to improve gut health and alleviate digestive issues. As more research emerges highlighting the benefits of probiotics, consumers are incorporating these products into their daily routines. This trend has led to an increase in the availability and variety of probiotic products in the market.Another trend in the market is the rising demand for over-the-counter (OTC) remedies. With busy lifestyles and limited access to healthcare professionals, consumers are turning to OTC products to self-treat minor digestive and intestinal issues. This trend has fueled the growth of the OTC segment in the Digestives & Intestinal Remedies market.

Local special circumstances: Australia has a high prevalence of digestive and intestinal disorders, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). These conditions affect a large portion of the population and create a significant demand for Digestives & Intestinal Remedies. The local special circumstances in Australia contribute to the growth of the market as consumers seek effective solutions to manage their symptoms and improve their quality of life.

Underlying macroeconomic factors: The Digestives & Intestinal Remedies market in Australia is also influenced by underlying macroeconomic factors. The country's aging population and increasing healthcare costs have led to a greater emphasis on preventive healthcare and self-management of health conditions. This has resulted in a higher demand for Digestives & Intestinal Remedies as consumers look for ways to address their digestive and intestinal issues without relying solely on medical interventions.In addition, the growing awareness of the importance of gut health and its impact on overall well-being has also contributed to the growth of the Digestives & Intestinal Remedies market in Australia. Consumers are recognizing the link between gut health and various health conditions, such as immune function and mental health, and are seeking products that can support and improve their gut health.In conclusion, the Digestives & Intestinal Remedies market in Australia is experiencing growth due to changing customer preferences towards natural and organic remedies, the popularity of probiotics, the demand for OTC products, the high prevalence of digestive and intestinal disorders, and underlying macroeconomic factors such as an aging population and increasing healthcare costs. These factors have created a favorable environment for the development and expansion of the Digestives & Intestinal Remedies market in Australia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.